The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Apr. 09, 2021
Applicant:
Verve Therapautics, Inc., Boston, MA (US);
Inventors:
Alexandra Chadwick, Somerville, MA (US);
Kallanthottathil G. Rajeev, Wayland, MA (US);
Ellen Rohde, Ashland, MA (US);
Christopher Cheng, North Reading, MA (US);
Caroline Reiss, Somerville, MA (US);
Assignee:
VERVE THERAPEUTICS, INC., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); A61K 9/127 (2006.01); A61K 31/7105 (2006.01); A61K 38/46 (2006.01); A61K 48/00 (2006.01); C07K 14/515 (2006.01); C12N 9/22 (2006.01); C12N 15/113 (2010.01); C12N 15/90 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); A61K 9/127 (2013.01); A61K 31/7105 (2013.01); A61K 38/465 (2013.01); C07K 14/515 (2013.01); C12N 9/22 (2013.01); C12N 15/11 (2013.01); C12N 15/113 (2013.01); C12N 15/907 (2013.01); C07K 2319/09 (2013.01); C07K 2319/80 (2013.01); C12N 2310/20 (2017.05); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/331 (2013.01); C12N 2310/335 (2013.01); C12N 2310/344 (2013.01); C12N 2310/3521 (2013.01); C12N 2800/80 (2013.01);
Abstract
Provided herein are compositions for gene modification or editing and methods of using same to treat or prevent certain conditions. Specific compositions and methods capable of safely and effectively editing gene targets expressed in the liver to durably lower LDL-C thereby treating a leading cause of cardiovascular disease are disclosed.